Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:03 AM
Ignite Modification Date:
2025-12-25 @ 1:03 AM
NCT ID:
NCT05498493
Eligibility Criteria:
Inclusion Criteria:
* Adults ≥18 years of age
* Have a confirmed SARS-CoV-2 infection (positive PCR or are serum antibody positive \[against spike protein if unvaccinated or N-capsid peptide if vaccinated\])
* Speak English
* Have objective mild to moderate cognitive impairment, which will be defined as impairment in executive function (a z-score \>1.5 standard deviations below the normative mean) and in at least one other cognitive domain
* Endorse comfort and familiarity with technology.
Exclusion Criteria:
* No method of contact
* Major neurocognitive disorder, as defined by a score \<17 on the Montreal Cognitive Assessment (MoCA)
* History of pre-COVID-19 neurologic disease (e.g., stroke)
* History of severe head injury (as defined by loss of consciousness \>30 minutes)
* Ongoing substance use disorder (Mini International Neuropsychiatric Interview Version 7.0.2 \[MINI\] or Alcohol Use Disorders Test-Consumption \[AUDIT-C\] \>8)
* Unstable medical, neurologic, or psychiatric conditions precluding participation in research activities, and
* Contraindication for MRI (e.g., metallic/electronic implants).
* Not involved in cognitive rehabilitation/training or daily meditative practices during study enrollment
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05498493
Study Brief:
Protocol Section:
NCT05498493